Loyal Valley Capital has led a RMB400 million ($62 million) Series B extension for EdiGene, a China-based biotech company that uses genome editing technologies to accelerate drug discovery.
BioTrack Capital and Sherpa Healthcare Partners came in as new investors, while existing backers such as IDG Capital, Lilly Asia Ventures (LAV), 3H Health Investment, Huagai Capital, Sequoia Capital China,...
Tealive, a teashop brand that has exploded across Malaysia in recent years, is ready for a concerted international expansion. Creador has been brought in to guide the process
Family offices have helped iGlobe Partners renew a lean and restrained deep tech VC mandate. A global investee network is hoped to facilitate overseas investments amid travel stoppages
The rapid ascent of single-asset continuation vehicles in the US and Europe might be emulated in Asia, but investors are approaching the market with measured optimism
ChrysCapital has exited Silicon Valley-based Infogain – an IT services provider that helped solidify the US-India cross-border opportunity set – to Apax Partners.